ARTICLE | 5 MIN

The Mask Comes Off: The Impact of Covid-19 on Emerging-Market Debt

March 6, 2020

Ironically, Covid-19 is unmasking the underlying weakness in emerging-market debt.

Introduction

What impact will Covid-19 have on emerging-market debt as the virus continues its world tour?

In a nutshell, we will remain negative on emerging-market (‘EM’) assets until we see evidence that the risks of a pandemic infection has subsided. We believe that most countries – both in developed, but particularly in emerging markets – do not have the ability to deal with a viral infection spread like China, which essentially enforced self-quarantine over millions of people, locked down major cities and provided expedited health care to thousands of infected citizens to curb the rate of contagion.

As a result, we believe we could experience a steep correction in both the local and external EM indexes driven by EM FX, credit and local rates.

What Could Drive the Correction?

We believe we could see a steep correction in both the local and external EM indexes for several reasons.

First, real-time activity indicators in days after the Chinese New Year already pose a worrisome outlook for EM debt: relative to the same period in 2019 (counting from the Chinese New Year onwards), coal consumption in China has fallen by 27%, 30-city property sales by 69%, the 100-city average transport and congestion index by 19% and passenger volume by railway by 75% (Figures 1-4).

Figure 1. Daily Coal Consumption of 6 IPPs

Figure 2. 30 Major Cities' Daily Property Sales

Figure 3. Transport Congestion Index

Figure 4. Passenger Volume

Source: UBS; as of 4 March 2020.

Secondly, the Chinese authorities have got a better handle of the situation than the US Federal government, in our view. The latter’s reaction has been driven by the US administration’s aim to keep activity strong and equity markets supported ahead of the upcoming presidential election and its effort to deal with the crisis has been disorganised. Furthermore, we also see a complacency over this crisis around the EM world, where the severity could be heightened by the lack of resources to deal with a major outbreak. We are concerned about the potential impact on global activity if the testing and preventive measures come too late.

Third, even ignoring the risk of contagion, we see limited fiscal headroom in many EM countries – such as Indonesia, South Africa, Turkey, Brazil and Colombia – to deal with a Chinese slowdown. The supply chain, which had already been hit pre virus by trade and geopolitical concerns, has become significantly more strained after the virus outbreak.

Fourth and contrary to market consensus, we continue to believe that the US dollar is not expensive. The market view that the US dollar is expensive is largely predicated on the Federal Reserve’s trade-weighted US dollar versus USDCNY (inverted), which shows how the US dollar appreciated during the 2010s (depicted by the blue line on Figure 5). The main reason for this move was the depreciation of the Chinese yuan versus the US dollar, which coincided with China becoming an important trading partner to the US.

Figure 5. Fed’s Trade-Weighted US Dollar Versus USDCNY (Inverted)

Source: Bloomberg; as of 4 March 2020.

Nevertheless, if the valuation of the US dollar is compared with other currencies that have been freely floating for the last three decades, it appears that ex-China, the US dollar is roughly in the middle of the range observed in the last 30 years (Figure 6).

Figure 6. Fed’s USD Trade-Weighted Against Major Currencies

Source: Bloomberg; As of 4 March 2020

So, the ‘expensive’ dollar view, expressed by the majority of market participants, is valid to the extent that one believes that Chinese yuan is very cheap versus the US dollar and thus has substantial potential for appreciation. Otherwise, the valuation of the US dollar shown in Figure 5 is just skewed by the yuan. However, over the last 15 years, the US current account balance/GDP has improved, while China’s has deteriorated. This has forced the Chinese government to tighten its capital controls to prevent outflows, which suggests limited appreciation potential of the yuan versus the US dollar, in our view.

The fifth reason is market positioning seems extremely stretched. Oversubscribed repo auctions and substantial repo funding has gone to finance large US Treasury cash positions, where hedge funds (and some additional market participants) arbitrage cash treasuries with futures (20-30 times levered). We see similar arbitrage activity across EM curves as they have been a low-vol (high-Sharpe ratio) source of return. Finally, quantitatively driven equity portfolios have been running several turns of leverage (albeit with neutral beta to benchmarks) to attempt to extract alpha, and momentum investors got caught close to limit long risk. This accumulation of leverage – in an environment where volatility has substantially increased – could easily trigger the unwind of the levered positions against a dealer community with no ability or appetite to provide liquidity.

Last but not least, we believe rate cuts by central banks will have limited impact on the supply disruption caused by this epidemic. At best, the rate cuts may be able to slow down the contraction in demand generated by the equity selloff, while hoping that supply comes back on line. Indeed, we rule out any meaningful proactive stimulus by the Bank of Japan or European Central Bank given they have run out of easing space.

Conclusion

In our opinion, EM countries have no room to maneuver in this environment and positions in EM assets have not been reduced in size. It took just one day worth of outflows (on 28 February) to drive EM rates to behave as risk and to create a disorderly widening in spreads. The anticipation of the Fed’s surprise cut halted what could have been the beginning of serious selling pressure. However, we are skeptical that market participants will be able to continue to hold on to their risk given the points made above.

For further clarification on the terms which appear here, please visit our Glossary page.

This information is communicated and/or distributed by the relevant Man entity identified below (collectively the "Company") subject to the following conditions and restriction in their respective jurisdictions.

Opinions expressed are those of the author and may not be shared by all personnel of Man Group plc (‘Man’). These opinions are subject to change without notice, are for information purposes only and do not constitute an offer or invitation to make an investment in any financial instrument or in any product to which the Company and/or its affiliates provides investment advisory or any other financial services. Any organisations, financial instrument or products described in this material are mentioned for reference purposes only which should not be considered a recommendation for their purchase or sale. Neither the Company nor the authors shall be liable to any person for any action taken on the basis of the information provided. Some statements contained in this material concerning goals, strategies, outlook or other non-historical matters may be forward-looking statements and are based on current indicators and expectations. These forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update or revise any forward-looking statements. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those contained in the statements. The Company and/or its affiliates may or may not have a position in any financial instrument mentioned and may or may not be actively trading in any such securities. Unless stated otherwise all information is provided by the Company. Past performance is not indicative of future results.

Unless stated otherwise this information is communicated by the relevant entity listed below.

Australia: To the extent this material is distributed in Australia it is communicated by Man Investments Australia Limited ABN 47 002 747 480 AFSL 240581, which is regulated by the Australian Securities & Investments Commission ('ASIC'). This information has been prepared without taking into account anyone’s objectives, financial situation or needs.

Austria/Germany/Liechtenstein: To the extent this material is distributed in Austria, Germany and/or Liechtenstein it is communicated by Man (Europe) AG, which is authorised and regulated by the Liechtenstein Financial Market Authority (FMA). Man (Europe) AG is registered in the Principality of Liechtenstein no. FL-0002.420.371-2. Man (Europe) AG is an associated participant in the investor compensation scheme, which is operated by the Deposit Guarantee and Investor Compensation Foundation PCC (FL-0002.039.614-1) and corresponds with EU law. Further information is available on the Foundation's website under www.eas-liechtenstein.li.

European Economic Area: Unless indicated otherwise this material is communicated in the European Economic Area by Man Asset Management (Ireland) Limited (‘MAMIL’) which is registered in Ireland under company number 250493 and has its registered office at 70 Sir John Rogerson's Quay, Grand Canal Dock, Dublin 2, Ireland. MAMIL is authorised and regulated by the Central Bank of Ireland under number C22513.

Hong Kong SAR: To the extent this material is distributed in Hong Kong SAR, this material is communicated by Man Investments (Hong Kong) Limited and has not been reviewed by the Securities and Futures Commission in Hong Kong.

Japan: To the extent this material is distributed in Japan it is communicated by Man Group Japan Limited, Financial Instruments Business Operator, Director of Kanto Local Finance Bureau (Financial instruments firms) No. 624 for the purpose of providing information on investment strategies, investment services, etc. provided by Man Group, and is not a disclosure document based on laws and regulations. This material can only be communicated only to professional investors (i.e. specific investors or institutional investors as defined under Financial Instruments Exchange Law) who may have sufficient knowledge and experience of related risks.

Switzerland: To the extent this material is made available in Switzerland the communicating entity is:

  • For Clients (as such term is defined in the Swiss Financial Services Act): Man Investments (CH) AG, Huobstrasse 3, 8808 Pfäffikon SZ, Switzerland. Man Investment (CH) AG is regulated by the Swiss Financial Market Supervisory Authority (‘FINMA’); and
  • For Financial Service Providers (as defined in Art. 3 d. of FINSA, which are not Clients): Man Investments AG, Huobstrasse 3, 8808 Pfäffikon SZ, Switzerland, which is regulated by FINMA.

United Kingdom: Unless indicated otherwise this material is communicated in the United Kingdom by Man Solutions Limited ('MSL') which is a private limited company registered in England and Wales under number 3385362. MSL is authorised and regulated by the UK Financial Conduct Authority (the 'FCA') under number 185637 and has its registered office at Riverbank House, 2 Swan Lane, London, EC4R 3AD, United Kingdom.

United States: To the extent this material is distributed in the United States, it is communicated and distributed by Man Investments, Inc. (‘Man Investments’). Man Investments is registered as a broker-dealer with the SEC and is a member of the Financial Industry Regulatory Authority (‘FINRA’). Man Investments is also a member of the Securities Investor Protection Corporation (‘SIPC’). Man Investments is a wholly owned subsidiary of Man Group plc. The registration and memberships described above in no way imply a certain level of skill or expertise or that the SEC, FINRA or the SIPC have endorsed Man Investments. Man Investments Inc, 1345 Avenue of the Americas, 21st Floor, New York, NY 10105.

This material is proprietary information and may not be reproduced or otherwise disseminated in whole or in part without prior written consent. Any data services and information available from public sources used in the creation of this material are believed to be reliable. However accuracy is not warranted or guaranteed. © Man 2025